| PAX5 antibodies | | | This is a review about PAX5 antibodies, based on 5 published articles using PAX5 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited PAX5 antibody. |
| BD Biosciences search BD Biosciences PAX5 products | | ih, wb | Transduction Laboratories monoclonal anti-PAX5 antibody that directed against a fixative-resistant epitope located in the octamer/homeodomain regions of the PAX5 protein was used in immunohistochemistry and western blot to study expression PAX5 in acute leukemias. to the paper | | ih | Transduction Laboratories monoclonal PAX5/BSAP (1:35) antibody was used in immunohistochemistry to study PAX5 expression in CD20-positive multiple myeloma. to the paper | | ih | Transduction Lab monoclonal PAX5/BSAP antibody (clone 24) was used in immunohistochemistry to detect PAX5/BSAP expression in human primary mediastinal (thymic) B-cell lymphoma (PMBL). to the paper |
| NOVOCASTRA | | ih | Novocastra PAX5 antibody was tested in immunohistochemistry by HPA (CAB001449) . to the paper |
| Articles Reviewed | | 1: | Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 | | 2: | Enrico Tiacci et al. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. 2004 | | 3: | Pei Lin et al. Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray. 2004 | | 4: | Manuel A Sepulveda et al. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. 2004 | | 5: | Stefano A Pileri et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. 2003 |
|